The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jeffrey M. Witkin

Psychiatric Drug Discovery

Lilly Research Laboratories

Lilly Corporate Center

Indianapolis

USA

[email]@lilly.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Psychiatric Drug Discovery, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA. 2002 - 2008
  • Drug Development Group, Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, USA. 2002

References

  1. The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors. Witkin, J.M., Levant, B., Zapata, A., Kaminski, R., Gasior, M. J. Pharmacol. Exp. Ther. (2008) [Pubmed]
  2. Metabotropic glutamate receptors in the control of mood disorders. Witkin, J.M., Marek, G.J., Johnson, B.G., Schoepp, D.D. CNS. Neurol. Disord. Drug. Targets (2007) [Pubmed]
  3. Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds. Witkin, J.M., Baez, M., Yu, J., Barton, M.E., Shannon, H.E. Epilepsy Res. (2007) [Pubmed]
  4. A role for cannabinoid CB1 receptors in mood and anxiety disorders. Witkin, J.M., Tzavara, E.T., Nomikos, G.G. Behav. Pharmacol (2005) [Pubmed]
  5. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. Witkin, J.M., Tzavara, E.T., Davis, R.J., Li, X., Nomikos, G.G. Trends Pharmacol. Sci. (2005) [Pubmed]
  6. A rapid punishment procedure for detection of anxiolytic compounds in mice. Witkin, J.M., Morrow, D., Li, X. Psychopharmacology (Berl.) (2004) [Pubmed]
  7. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907]. Witkin, J.M., Dijkstra, D., Levant, B., Akunne, H.C., Zapata, A., Peters, S., Shannon, H.E., Gasior, M. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  8. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Witkin, J.M., Nelson, D.L. Pharmacol. Ther. (2004) [Pubmed]
  9. NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Witkin, J.M., Gasior, M., Schad, C., Zapata, A., Shippenberg, T., Hartman, T., Slusher, B.S. Neuropharmacology (2002) [Pubmed]
  10. Some contextual and historical determinants of the effects of chlordiazepoxide on punished responding of rats. Witkin, J.M. Psychopharmacology (Berl.) (2002) [Pubmed]
 
WikiGenes - Universities